{"disease":{"id":"mpox","name":"mpox"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07093489","title":"Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":11990,"lead_sponsor_name":"International Vaccine Institute","has_results":false},{"nct_id":"NCT05522296","title":"Break-through Infection Following Mpox vaccinatIon","phase":"","overall_status":"COMPLETED","enrollment_count":3125,"lead_sponsor_name":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","has_results":false},{"nct_id":"NCT06840860","title":"Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT07199569","title":"Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":970,"lead_sponsor_name":"Bavarian Nordic","has_results":false},{"nct_id":"NCT05534984","title":"Study of Tecovirimat for Human Mpox Virus","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":719,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06839989","title":"An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT07267390","title":"Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts","phase":"","overall_status":"RECRUITING","enrollment_count":550,"lead_sponsor_name":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","has_results":false},{"nct_id":"NCT06549530","title":"Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":460,"lead_sponsor_name":"Bavarian Nordic","has_results":false},{"nct_id":"NCT06353737","title":"Looking for Asymptomatic Mpox in a Population at High Risk","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT05995275","title":"A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":351,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT06721585","title":"Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only","phase":"","overall_status":"COMPLETED","enrollment_count":328,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT06579885","title":"Ocular Complications of Mpox in the Democratic Republic Congo","phase":"","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT07499739","title":"Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT06136117","title":"Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts","phase":"","overall_status":"COMPLETED","enrollment_count":257,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT07253675","title":"Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Shanghai Institute Of Biological Products","has_results":false},{"nct_id":"NCT06984705","title":"Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":144,"lead_sponsor_name":"Osaka Metropolitan University","has_results":false},{"nct_id":"NCT07055867","title":"Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":122,"lead_sponsor_name":"Osaka Metropolitan University","has_results":false},{"nct_id":"NCT07067723","title":"Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":122,"lead_sponsor_name":"Osaka Metropolitan University","has_results":false},{"nct_id":"NCT07342829","title":"Prospective Follow-up After MVA-BN Booster Vaccination","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":95,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false}],"total":19},"guidelines":[],"source":"Drug Landscape verified database"}